|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
GB2189698A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
|
GB2189699A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
CH677886A5
(cg-RX-API-DMAC10.html)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
ZA935112B
(en)
*
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9221220D0
(en)
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
|
US5302584A
(en)
|
1992-10-13 |
1994-04-12 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
BR9408323A
(pt)
*
|
1993-12-17 |
1997-08-19 |
Sandoz Ag |
Derivados de rapamicina
|
|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
FR2730932B1
(fr)
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
|
DE69624921T2
(de)
|
1995-06-09 |
2003-09-11 |
Novartis Ag, Basel |
Rapamycinderivate
|
|
FR2742676B1
(fr)
|
1995-12-21 |
1998-02-06 |
Oreal |
Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
|
|
CA2259420C
(en)
|
1996-07-05 |
2007-09-18 |
Biotica Technology Limited |
Erythromycins and process for their preparation
|
|
US5922730A
(en)
*
|
1996-09-09 |
1999-07-13 |
American Home Products Corporation |
Alkylated rapamycin derivatives
|
|
FR2755854B1
(fr)
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
|
FR2760970B1
(fr)
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
|
FR2787027B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787026B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters mixtes d'acide gras ou d'alcool gras, d'acide carboxylique et de glyceryle, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787326B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787325B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2787703B1
(fr)
|
1998-12-29 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788007B1
(fr)
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788449B1
(fr)
|
1999-01-14 |
2001-02-16 |
Oreal |
Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2789076B1
(fr)
|
1999-02-02 |
2001-03-02 |
Synthelabo |
Derives de alpha-azacyclomethyl quinoleine, leur preparation et leur application en therapeutique
|
|
IL147803A0
(en)
|
1999-08-24 |
2002-08-14 |
Ariad Gene Therapeutics Inc |
28-epirapalogs
|
|
AU2001248588B2
(en)
|
2000-04-13 |
2006-02-02 |
Biotica Technology Limited |
Hybrid glycosylated products and their production and use
|
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
|
FR2811564B1
(fr)
|
2000-07-13 |
2002-12-27 |
Oreal |
Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
WO2002055562A2
(en)
|
2001-01-11 |
2002-07-18 |
Eastman Chem Co |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
FR2819427B1
(fr)
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
EP2545937A1
(en)
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
GB0128680D0
(en)
|
2001-11-29 |
2002-01-23 |
Biotica Tech Ltd |
Hybrid glycosylated products and their production and use
|
|
ES2544624T3
(es)
|
2002-07-16 |
2015-09-02 |
Buck Institute For Research On Aging |
Producción de policétidos
|
|
US7476393B2
(en)
|
2002-11-29 |
2009-01-13 |
L'oreal |
Process for the preparation of a cationic nanoemulsion, and cosmetic composition
|
|
US7160867B2
(en)
|
2003-05-16 |
2007-01-09 |
Isotechnika, Inc. |
Rapamycin carbohydrate derivatives
|
|
US7220755B2
(en)
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
|
US7468402B2
(en)
|
2004-03-17 |
2008-12-23 |
Baker Hughes Incorporated |
Polymeric nanoemulsion as drag reducer for multiphase flow
|
|
RU2394036C2
(ru)
*
|
2004-12-20 |
2010-07-10 |
Вайет |
Аналоги рапамицина и их применение при лечении неврологических, пролиферативных и воспалительных заболеваний
|
|
EP1896075A2
(en)
*
|
2005-06-22 |
2008-03-12 |
LifeCycle Pharma A/S |
Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
|
|
GB0601406D0
(en)
|
2006-01-24 |
2006-03-08 |
Novartis Ag |
Organic Compounds
|
|
WO2009131631A1
(en)
|
2008-04-14 |
2009-10-29 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
|
AP2011005707A0
(en)
|
2008-11-11 |
2011-06-30 |
Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd |
Inclusion complexes of pinocembrin with cyclodextrin or its derivatives.
|
|
CN103391780B
(zh)
|
2011-02-16 |
2015-08-19 |
诺瓦提斯公司 |
用于治疗神经变性疾病的治疗剂的组合物
|
|
CN102731527A
(zh)
|
2012-07-12 |
2012-10-17 |
浙江医药股份有限公司新昌制药厂 |
一种西罗莫司42－醚衍生物的合成方法
|
|
WO2014153118A1
(en)
|
2013-03-14 |
2014-09-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
|
|
WO2015142661A1
(en)
|
2014-03-15 |
2015-09-24 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
EP3193902A4
(en)
*
|
2014-09-11 |
2018-03-28 |
The Regents of The University of California |
mTORC1 INHIBITORS
|
|
CN104341434B
(zh)
|
2014-10-16 |
2016-04-06 |
福建省微生物研究所 |
取代的雷帕霉素三氮唑衍生物和用途
|
|
US20180258100A1
(en)
*
|
2015-08-28 |
2018-09-13 |
Matthew Alan Gregory |
RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY
|
|
US20190022073A1
(en)
*
|
2015-09-03 |
2019-01-24 |
Nippon Kayaku Kabushiki Kaisha |
Pharmaceutical composition comprising rapamycin or derivative thereof
|
|
US10683308B2
(en)
|
2015-09-11 |
2020-06-16 |
Navitor Pharmaceuticals, Inc. |
Rapamycin analogs and uses thereof
|
|
CN108926533B
(zh)
*
|
2017-05-24 |
2022-03-25 |
江苏天士力帝益药业有限公司 |
一种替西罗莫司脂质体及其制备方法
|
|
UY37900A
(es)
|
2017-09-26 |
2019-04-30 |
Novartis Ag |
Nuevos derivados de rapamicina
|
|
US10980784B2
(en)
|
2018-06-15 |
2021-04-20 |
Navitor Pharmaceuticals, Inc. |
Rapamycin analogs and uses thereof
|
|
WO2020076738A2
(en)
|
2018-10-12 |
2020-04-16 |
Bellicum Pharmaceuticals, Inc |
Protein-binding compounds
|
|
WO2020097258A1
(en)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
LT3898637T
(lt)
|
2018-12-18 |
2025-03-10 |
Novartis Ag |
Rapamicino dariniai
|
|
CA3127448C
(en)
|
2019-01-22 |
2024-06-04 |
Aeovian Pharmaceuticals, Inc. |
Mtorc modulators and uses thereof
|
|
EP4069223A4
(en)
|
2019-12-05 |
2023-12-20 |
Janssen Pharmaceutica NV |
RAPAMYCIN ANALOGS AND THEIR USES
|
|
CN115776907B
(zh)
|
2020-03-27 |
2025-02-25 |
艾奥维安制药公司 |
Mtorc1调节剂及其用途
|
|
CN121426814A
(zh)
|
2020-07-21 |
2026-01-30 |
艾奥维安制药公司 |
Mtorc1调节剂及其用途
|
|
JP2024503898A
(ja)
|
2021-01-22 |
2024-01-29 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ラパマイシン類似体及びその使用
|